A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia - Related Studies

A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia

This study has been completed.

Study NCT00001689. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Acute Lymphocytic Leukemia
		Leukemia

2	Additional conditions recognized in this trial
		Leukemia, Lymphoid
		Precursor Cell Lymphoblastic Leukemia-Lymphoma

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		Vincristine

5	More general drug interventions related to this trial
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		National Cancer Institute (NCI)